Preliminary findings show that ' ipilimumab' shrinks prostrate tumours to operable size.
Saturday, 20 June 2009
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Low Dose Naltrexone is simply a much smaller dosage (Typically 1/50) of a 30 year old proven drug called Naltrexone. LDN has increasingly been shown to put a wide variety of auto-immune and other conditions (e.g. Crohn's Disease, Multiple Sclerosis (MS) into remission with virtually no side effects.
Follow us on twitter
Posts
Links
- Low Dose Naltrexone and IBD Yahoo! Group
- Low Dose Naltreone Yahoo! Group
- UK Petition for NHS Funding for an LDN Trial
- LDN on the NHS Blog
- The Essential Health Clinic Glasgow
- Google LDN by Joseph Wouk
- National Association for Colitis and Crohn's Disease (UK)
- LDN Research Trust
- lowdosenaltrexone.org
- LDNers
- Bob Thomson's LDN Experience
- LDN Now (UK)
Ads on this Site
Please note, any income form Google AdSense ads on this site is donated to The Mulitiple Sclerosis Resource Centre - http://msrc.co.uk
Blog Archive
-
▼
2009
(72)
-
▼
June
(12)
- Global Autoimmune Disease Therapeutics Market to R...
- A Low Dose Naltrexone (LDN) Journal - Advice on Sk...
- US Democrats Produce Draft Plan for Universal Heal...
- Immune Response Stimulating Drug Found to Reduce P...
- New Yahoo! Group for Low Dose Naltrexone (LDN) Use...
- A New Low Dose Naltrexone (LDN) Petition for Austr...
- Crohn's Disease Put into Remission in Children wit...
- LOw-Dose Naltrexone for Fibromyalgia & Chronic Fat...
- Low Dose Naltrexone : The Next Miracle Drug?
- UK Low Dose Naltrexone (LDN) NHS Trial Petition Su...
- MS Patient Blog - Improvement Continuing Using Low...
- Interview with Dr Burton Berkson on Low Dose Naltr...
-
▼
June
(12)
About Me
Followers
What is Low Dose Naltrexone (LDN)?
Low Dose Naltrexone is simply a much smaller dosage (Typically 1/50) of a 30 year old proven drug called Naltrexone. LDN has increasingly been shown to put a wide variety of auto-immune and other conditions into remission with virtually no side effects.
No comments:
Post a Comment